{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:53:27Z","timestamp":1792976007404,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.arth.2026.04.017","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:19:17Z","timestamp":1776467957000},"page":"S111-S118.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["Delayed Administration of Apixaban and Rivaroxaban is Associated with Reduced Rates of Postoperative Bleeding Without Increasing Thromboembolic Risk Following Elective Total Hip Arthroplasty"],"prefix":"10.1016","volume":"41","author":[{"given":"McKenzie W.","family":"Culler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil S.","family":"Telang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-1702","authenticated-orcid":false,"given":"Nathanael D.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2026.04.017_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.arth.2019.08.049","article-title":"Have venous thromboembolism rates decreased in total hip and knee arthroplasty?","volume":"35","author":"Warren","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.04.017_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.artd.2018.02.014","article-title":"What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients?","volume":"4","author":"Shahi","year":"2018","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2026.04.017_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45883","article-title":"Venous thromboembolism in total hip and total knee arthroplasty","volume":"6","author":"Simon","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arth.2026.04.017_bib4","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.5435\/JAAOS-D-22-00708","article-title":"Trends of venous thromboembolism after total hip arthroplasty in the United States: analysis from 2011 to 2019","volume":"31","author":"Agarwal","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2026.04.017_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/medicina56090416","article-title":"An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020","volume":"56","author":"Santana","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.arth.2026.04.017_bib6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2106\/JBJS.20.02250","article-title":"Venous thromboembolic prophylaxis after total hip and knee arthroplasty","volume":"103","author":"Lieberman","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2026.04.017_bib7","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.004","article-title":"Direct oral anticoagulant agents: pharmacologic profile, indications, coagulation monitoring, and reversal agents","volume":"27","author":"Rose","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.arth.2026.04.017_bib8","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s11606-020-05904-0","article-title":"Oral anticoagulant utilization in the United States and United Kingdom","volume":"35","author":"Colacci","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.arth.2026.04.017_bib9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.arth.2023.02.028","article-title":"Safety and efficacy of rivaroxaban in primary total hip and knee arthroplasty","volume":"38","author":"Piple","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.04.017_bib10","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2026.04.017_bib11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1302\/0301-620X.94B11.28955","article-title":"The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme: results from the RECORD programme","volume":"94","author":"Lassen","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2026.04.017_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1160\/TH10-09-0601","article-title":"Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies","volume":"105","author":"Turpie","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arth.2026.04.017_bib13","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.arth.2025.03.072","article-title":"Effects and complications of apixaban versus aspirin for venous thromboembolism prophylaxis after total hip or knee arthroplasty","volume":"40","author":"Chokshi","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.04.017_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.arth.2017.08.039","article-title":"Increased incidence of bleeding and wound complications with factor-Xa inhibitors after total joint arthroplasty","volume":"33","author":"Garfinkel","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.04.017_bib15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/1076029618772337","article-title":"Comparison of postoperative bleeding in total hip and knee arthroplasty patients receiving rivaroxaban, enoxaparin, or aspirin for thromboprophylaxis","volume":"24","author":"Lindquist","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.arth.2026.04.017_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5435\/JAAOS-D-15-00760","article-title":"Venous thromboembolism prophylaxis in total hip arthroplasty and total knee arthroplasty patients: from guidelines to practice","volume":"25","author":"Lieberman","year":"2017","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2026.04.017_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijrobp.2021.08.007","article-title":"Logistic regression in clinical studies","volume":"112","author":"Zabor","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.arth.2026.04.017_bib19","author":"Bayer"},{"key":"10.1016\/j.arth.2026.04.017_bib21","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2026.04.017_bib22","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2026.04.017_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/phar.1608","article-title":"Retrospective evaluation of postoperative bleeding events in patients receiving rivaroxaban after undergoing total hip and total knee arthroplasty: Comparison with clinical trial data","volume":"35","author":"Wood","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.arth.2026.04.017_bib25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MBC.0000000000000121","article-title":"Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty","volume":"25","author":"Zou","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.arth.2026.04.017_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.arth.2007.03.007","article-title":"Does \u201cexcessive\u201d anticoagulation predispose to periprosthetic infection?","volume":"22","author":"Parvizi","year":"2007","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.04.017_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1302\/0301-620X.89B6.18844","article-title":"Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry: findings from the global orthopaedic registry","volume":"89","author":"Warwick","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2026.04.017_bib28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1302\/0301-620X.94B12.29358","article-title":"Increased one-year risk of symptomatic venous thromboembolism following total hip replacement: a nationwide cohort study: a nationwide cohort study","volume":"94","author":"Pedersen","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2026.04.017_bib29","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.158.14.1525","article-title":"Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arth.2026.04.017_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/00016470052943883","article-title":"Late occurring clinical deep vein thrombosis in joint-operated patients","volume":"71","author":"Dahl","year":"2000","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.arth.2026.04.017_bib31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1213\/ane.0b013e31819bcc9c","article-title":"Blood coagulation: hemostasis and thrombin regulation","volume":"108","author":"Tanaka","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.arth.2026.04.017_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2006.11.004","article-title":"Coagulation 2006: a modern view of hemostasis","volume":"21","author":"Hoffman","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.arth.2026.04.017_bib33","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1378\/chest.124.3_suppl.33S","article-title":"Thrombin and fibrinolysis","volume":"124","author":"Nesheim","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.arth.2026.04.017_bib34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: a clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.arth.2026.04.017_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.arth.2026.04.017_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1472-8206.2011.00981.x","article-title":"Pharmacodynamic and pharmacokinetic basics of rivaroxaban: pharmacodynamic and pharmacokinetic basics of rivaroxaban","volume":"26","author":"Kreutz","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.arth.2026.04.017_bib37","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1016\/j.arth.2023.02.066","article-title":"Aspirin for venous thromboembolic prophylaxis following total hip and total knee arthroplasty: an analysis of safety and efficacy accounting for surgeon selection bias","volume":"38","author":"Heckmann","year":"2023","journal-title":"J Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326003517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326003517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T10:00:36Z","timestamp":1787392836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540326003517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0883540326003517"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2026.04.017","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed Administration of Apixaban and Rivaroxaban is Associated with Reduced Rates of Postoperative Bleeding Without Increasing Thromboembolic Risk Following Elective Total Hip Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2026.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}